<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000410.v1.p1" parentStudy="phs000410.v1.p1" createDate="2011-09-13" modDate="2014-03-12">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Ulrike Peters, PhD</td><td>Fred Hutchinson Cancer Research Center, Seattle, WA, USA</td></tr>
		<tr><td>Co-Investigator</td><td>Martha Slattery, PhD</td><td>University of Utah, Salt Lake City, UT, USA</td></tr>
		<tr><td>Co-Investigator</td><td>John Potter, PhD</td><td>Fred Hutchinson Cancer Research Center, Seattle, WA, USA</td></tr>
		<tr><td>Co-Investigator</td><td>Charles Kooperberg, PhD</td><td>Fred Hutchinson Cancer Research Center, Seattle, WA, USA</td></tr>
		<tr><td>Funding Source</td><td>U01 CA137088</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Whole Exome Sequencing for Colorectal Cancer</StudyNameEntrez>
	<StudyNameReportPage>Whole Exome Sequencing for Colorectal Cancer</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>This project was designed to use next generation sequencing technology to screen the protein coding regions of the genome for low frequency variants in a panel of high-risk colorectal adenocarcinoma cases.</p> <p>Blood and cell-line DNA for colorectal cancer patients and a subset of quality control samples that had existing whole exome sequence data were analyzed using Illumina HiSeq sequencers. Samples from this project were from participants in the Women&#39;s Health Initiative (WHI) and the Diet, Activity, and Lifestyle Study (DALS).</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>DALS and WHI have study-specific inclusion and exclusion criteria, which can be found in the selected publications. The composition of this study includes un-related Caucasian participants with colorectal adenocarcinoma and a subset of controls. Cases were selected based on having one or more first-degree relatives with colorectal cancer and/or early onset of colorectal cancer (age at diagnosis &lt;55 years). Cases with the following diagnoses related to the colon or rectum were excluded: any <i>in situ</i> adenocarcinoma or carcinoma, (large cell) neuroendocrine carcinoma, squamous cell carcinoma, carcinoid tumor, Goblet cell carcinoid, and any type of lymphoma, including non-Hodgkin, Mantle cell, large B-cell, or follicular lymphoma.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="8859178"/>
		</Publication>
		<Publication>
			<Pubmed pmid="9427430"/>
		</Publication>
		<Publication>
			<Pubmed pmid="8988044"/>
		</Publication>
		<Publication>
			<Pubmed pmid="9492970"/>
		</Publication>
		<Publication>
			<Pubmed pmid="12117397"/>
		</Publication>
		<Publication>
			<Pubmed pmid="16467233"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Colorectal Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Sequence Analysis, DNA"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Ulrike Peters, PhD</AttName>
			<Institution>Fred Hutchinson Cancer Research Center, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Martha Slattery, PhD</AttName>
			<Institution>University of Utah, Salt Lake City, UT, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>John Potter, PhD</AttName>
			<Institution>Fred Hutchinson Cancer Research Center, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Charles Kooperberg, PhD</AttName>
			<Institution>Fred Hutchinson Cancer Research Center, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>U01 CA137088</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>R01 CA48998</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>N01 WH22110</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>N01 WH24152</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>N01 WH32100-2</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>N01 WH32105-6</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>N01 WH32108-9</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>N01 WH32111-13</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>N01 WH32115</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>N01 WH32118-32119</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>N01 WH32122</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>N01 WH42107-26</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>N01 WH42129-32</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>N01 WH44221</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Sequencing Center">
			<AttName>X01 HG006196-01</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyURLs>
		<Url name="Women&#39;s Health Initiative" url="http://www.whiscience.org/"/>
	</StudyURLs>
	<StudyHistory><![CDATA[
<p>The Diet, Activity, and Lifestyle Study (DALS) is a case-control study that recruited participants diagnosed with first-primary colon cancer between October 1991 and September 1994. The majority of cases were interviewed within four months of diagnosis and verified through state-wide tumor registries. The study continues to conduct analyses, with a particular focus on tumor characteristics, and the environmental and genetic risk factors for colon cancer.</p> <p>The Women&#39;s Health Initiative (WHI) recruited participants for a randomized Clinical Trial (CT) between September 1993 and October 1998 and an Observational Study (OS) between September 1993 and December 1998. OS participants were followed for 8 to 12 years, during which annual self-administered questionnaires or clinic follow-up visits were completed. The WHI CT closed between October 2004 and March 2005, at which point participants were given the opportunity to enroll in the WHI Extension Study, which has ongoing annual follow-up.</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU-MDS" longName="General Research Use (MDS)"/>
		<ConsentGroup groupNum="2" shortName="GRU-NPU-MDS" longName="General Research Use (NPU, MDS)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NCI</DacName>
      <DacFullName>NCI</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000410.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000410.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000410.v1.p1" FileName="DUC_Sequencing_Colorectal_Cancer_9.27.11.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use (MDS)</ConsentName>
        <ConsentAbbrev>GRU-MDS</ConsentAbbrev>
        <UseLimitation>Use of the data is limited only by the terms of the model Data Use Certification.
Use of the data includes methods development research (e.g., development of software or algorithms).</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
      <ParticipantSet groupNum-REF="2">
        <ConsentName>General Research Use (NPU, MDS)</ConsentName>
        <ConsentAbbrev>GRU-NPU-MDS</ConsentAbbrev>
        <UseLimitation>Use of the data is limited only by the terms of the model Data Use Certification.
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
